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SUMMARY
The question of whether HIV-1 RNA in cerebrospinal fluid (CSF) is derived from viral replication in the central nervous system 
or simply reflects the transit of infected lymphocytes from the blood compartment has long been a matter of debate. Some studies 
found no correlation between CSF and plasma viral load, whereas others did. The lack of a correlation between the two compartments 
suggests that the presence of HIV-1 RNA is not simply due to the passive passage of the virus from blood to CSF but rather due to 
intrathecal replication. To evaluate the correlation between plasma and CSF HIV-1 RNA levels and to identify situations in which 
there is no correlation between the two compartments, seventy patients were prospectively studied. The association between CSF and 
plasma viral load was evaluated in the total population and in subgroups of patients with similar characteristics. A correlation between 
the CSF and plasma compartments was observed for patients undergoing highly active antiretroviral therapy (HAART), those with a 
CD4 T lymphocyte count lower than 200 cells/mm3, and those with increased CSF protein content. On the other hand, no correlation 
was observed for patients without adequate virological control, who had a CD4 count higher than 200 cells/mm3 and who did not 
use HAART. The correlation between the two compartments observed in some patients suggests that CSF HIV-1 RNA levels may 
reflect plasma levels in these subjects. In contrast, the lack of a correlation between the two compartments in patients who were not 
on HAART and who had normal CSF proteins and a poor virological control possibly indicates compartmentalization of the virus in 
CSF and, consequently, plasma-independent intrathecal viral replication. 
KEYWORDS: AIDS; HIV; Cerebrospinal fluid; HIV-1 RNA; Opportunistic infections; Viral load; Neurological.
INTRODUCTION
Plasma HIV-1 RNA levels indicate the status of systemic viral 
replication and represent the best predictive marker of HIV-1 disease 
progression (MELLORS 1995) and the most important tool for 
monitoring the response to antiretroviral (ARV) therapy (PIATAK et al. 
1993, PERELSON et al. 1996, MELLORS et al. 1997). Quantitative 
amplification techniques of HIV-1 RNA in different body fluids, including 
cerebrospinal fluid (CSF), have been applied to HIV-infected adults and 
children but, in contrast to plasma HIV levels, their predictive value has 
not been well established (McARTHUR et al. 2003, MARRA et al. 2003). 
Quantitative studies generally show higher mean and median HIV-
1 RNA levels in plasma than in CSF, but higher CSF levels have been 
reported in certain cases (CINQUE et al. 2000, DE LUCA et al. 2002, 
LAFEUILLADE et al. 1996, BURGER et al. 1997). Some investigators 
found no correlation between CSF and plasma viral load (BREW et al. 
1997, ELLIS et al. 1997, CINQUE et al. 1998, MARTIN et al. 1998, 
FOUDRAINE et al. 1998, SCHRAGER et al. 1998, ANTINORI et 
al. 2002), while others did (McARTHUR et al. 1997, BOSSI et al. 
1998, ROBERTSON et al. 1998, GARCIA et al. 1999). The lack of a 
correlation between the two compartments suggests that the presence 
of HIV-1 RNA may not simply be due to passive passage of the virus 
from blood to CSF but rather to intrathecal replication (CINQUE et al. 
1998, SMITH et al. 2009). 
The question of whether HIV-1 RNA in cerebrospinal fluid (CSF) is 
derived from viral replication in the central nervous system or simply reflects 
the transit of infected lymphocytes from the blood compartment has long been 
a matter of debate. This is important because it involves the validity of the 
measurement of HIV RNA levels in CSF as a replacement of brain viral load 
(CINQUE et al. 2000). The objective of the present study was to evaluate the 
correlation between plasma and CSF HIV-1 RNA levels in individuals with 
a suspicion of opportunistic neurological disease and to identify situations 
in which there is no correlation between the two compartments.
MATERIALS AND METHODS
Seventy patients undergoing lumbar puncture as part of a work-up 
for HIV seropositive individuals with a suspicion of neurological disease 
hospitalized at a referral hospital for infectology in the State of Minas 
Gerais, Brazil, were prospectively studied. The study was approved by 
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the Ethics Committee of the Hospital and consent was obtained from 
all participants.
In the case of patients without neurological diseases the clinical 
diagnoses were primary headache, metabolic/toxic disorders, and fever 
with a non-neurological focus. 
Clinical and laboratory data including gender, age, use or not 
of combination antiretroviral therapy (ART), presence and type of 
neurological disease, CD4+ T lymphocyte count, and CSF cell count 
and protein content were collected.
CSF and plasma samples were collected within an interval of 48 
hours between each other. HIV-1 RNA was quantified by the nucleic 
acid sequence based amplification (NASBA) technique using centrifuged 
plasma and not centrifuged CSF according to manufacturer instructions 
(Nuclisens HIV-1 QT, Organon TeKniKa, Boxtel, Netherlands), with a 
sensitivity of 80 copies/mL (1.90 log10 copies/mL). 
 The association between viral load in the CSF and plasma 
compartments was evaluated using Spearman’s correlation coefficient. 
To evaluate the existence of statistically significant difference between 
frequencies, Chi-square test was used. P values < 0.05 were considered 
to indicate statistical significance. CSF and plasma viral loads were log10 
transformed since the HIV-1 RNA levels showed no normal distribution 
and there is big variation of the minimum and maximum viral load. 
Patients with undetectable viral load were assigned a value of 1, so 
the viral load in the logarithmic scale was 0 to avoid the problem of 
expressing zero logarithmically. All statistical analyses were performed 
with the SPSS 8.0 program (SPSS Inc.). 
RESULTS
 Characteristics of the study population are summarized in Table 1. 
Twelve of the 70 patients studied were without neurological disease and 
58 had active neurological diseases. The median CD4+ lymphocyte count 
was 83 cells/mm3 in the population studied, with the median count being 
61 cells/mm3 in patients without neurological disease and 88 cells/mm3 
in patients with active neurological diseases. Twelve patients had a 
CD4+ count higher than 200 cells/mm3. No differences in median CD4+ 
lymphocyte count were observed between patients with and without 
active neurological disease or between patients who used HAART and 
those who did not.
The median cell count was 5 cells/mm3 and the median protein 
concentration was 61 mg/dL. The CSF protein content was higher than 
45 mg/dL in 44 (63%) patients and the number of CSF cells was higher 
than 5 cells/mm3 in 35 (50%) patients. The median cell count was 
8 cells/mm3 in patients with active neurological disease and 2 cells/mm3 in 
those without neurological disease (p < 0.0001); median protein content 
was 63 and 38 mg/dL, respectively (p = 0.084). 
Among the 70 patients studied, HIV-1 RNA was detected in 42 CSF 
samples and in 56 plasma samples (detection limit: 80 copies/mL), with 
viral RNA greater than the detection limit being detected in the two 
compartments in 40 patients. Among 35 patients using HAART, HIV 
RNA was detected in CSF in 14 patients, in plasma in 22, and in 18 
patients at both compartments.
The median CSF viral load was 2.81 log10 copies/mL in the total 
population, 3.27 log10 copies/mL in patients with active neurological 
disease, and < 1.9 log10 copies/mL in patients without neurological disease 
(p < 001). The median plasma viral load was 4.28, 4.35 and 2.45 log10 
copies/mL, respectively (p < 001). The median CSF and plasma viral 
loads were < 1.9 and 2.69 log10 copies/mL in patients undergoing HAART 
and 3.76 and 5.08 log10 copies/mL in those not receiving HAART, 
respectively. All these results showed statistically significant differences.
Correlation between CSF and plasma viral load: a significant 
correlation between the two compartments was observed in the total 
population (70 patients) (r = 0.543, p < 0.001). However, no correlation 
between the two compartments was found when only patients with 
CSF and plasma viral loads higher than the detection limit (40 patients) 
were considered (r = 0.242, p = 0.132). A correlation between the two 
compartments continued to be observed when the patients were divided 
into groups with (58 patients) and without active neurological disease 
(12 patients) (r = 0.516, p < 0.001 and r = 0.633, p = 0.027, respectively).
The patients were also divided according to immunological state, 
measured by CD4+ lymphocyte count into those with a count higher (12 
patients) and lower (58 patients) than 200 cells/mm3. A correlation between 
Table 1
Characteristics of the 70 subjects studied
Mean age [years (interquartile range)] 37(20-60)
Sex (n):
   Male 50
   Female 20
CD4-positive cells (cells/mm3):
   Mean 142
   Median 83
   Range 1-405 
Pre-existing ARV therapy (n): 12
   Yes 35
   No 35
Mean duration of ARV therapy [months (interquar-
tile range)]
10.4 (0.5-60)
Neurologically asymptomatic (n) 12
Neurologically symptomatic (n): 58
   HIV-associated dementia 5
   Vacuolar myelopathy 1
   Opportunistic CNS infections:
       Toxoplasmosis 16
       Cryptococcal meningitis 12
       Tuberculosis meningitis 3
        PML 1
        Opportunistic CNS infections associations:
             Cryptococcal and tuberculous 2
             Cryptococcal and toxoplasmosis 1
             Cryptococcal and vacuolar myelopathy 1
   Other (stroke, brain abscess, neuropathy) 3
   Undetermined neurological diagnosis 13
ARV: antiretroviral drug; CNS: central nervous system; PML: progres-
sive multifocal leukoencephalopathy.
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the two compartments was observed in patients with a CD4+ count lower 
than 200 cell/mm3 (r = 0.507, p < 0.001) and no correlation was found in 
patients with a CD4+ count higher than 200 cells/mm3 (r = 0.530, p = 0.077). 
With respect to the use of HAART, there was a correlation between 
compartments in the group that used HAART (r = 0.498, p = 0.002), 
and no correlation in the group who did not (r = 0.250, p = 0.148).
When dividing the patients according to CSF protein content, a 
correlation between CSF and plasma viral load was observed in those 
with increased protein (r = 0.608, p < 0.001) and no correlation in those 
with normal protein content (r = 0.280, p = 0.195).
DISCUSSION
In the present study, a correlation between the CSF and plasma 
compartments was observed in the total population which, in principle, 
may indicate that CSF HIV-1 RNA levels reflect plasma levels. However, 
the separate calculation of correlation in groups of patients with common 
characteristics revealed the absence of a correlation in certain situations, 
a finding suggesting the occurrence of HIV-1 compartmentalization in 
CSF in some patients.
No correlation between the two compartments was observed when 
only patients with a detectable viral load in CSF and plasma, and therefore 
without virological control, were considered for analysis. Patients with a 
plasma and CSF viral load lower than the detection limit were those who 
most frequently used HAART and were responsible for the existence of 
a correlation on statistical analysis. However, when these patients were 
excluded from analysis, no correlation between the two compartments 
was observed in patients not controlled by HAART therapy (viral load > 
80 copies/mL), suggesting that the use of ARV drugs is responsible for 
virological control in plasma and CSF and that compartmentalization of 
HIV-1 RNA in CSF may have occurred in not well-controlled patients. 
No correlation between CSF and plasma viral load was observed in 
patients with higher viral replication in plasma and CSF. This fact 
was also reported by DE LUCA et al. (2002) who found a correlation 
between CSF and plasma viral load, but this correlation was no longer 
observed when only patients with a high CSF (> 4.0 log10/mL) and plasma 
(> 5.0 log10/mL) viral load were included, and continued to be observed 
in those with lower CSF and plasma HIV-1 RNA levels.
When the patients were divided into groups with and without active 
neurological disease, a correlation between the two compartments was 
observed in both groups, demonstrating that this correlation does not depend 
on the isolated presence or absence of neurological disease. A correlation 
between the two compartments has been shown in asymptomatic subjects 
(GARCIA et al. 1999), while no correlation has been found in patients 
with more advanced disease, with HIV affecting the central nervous 
system, or in patients with opportunistic diseases (CINQUE et al. 1998). 
Opportunistic neurological diseases increase HIV-1 RNA levels in the CSF 
and plasma, but the increase is more significant in CSF (CHRISTO et al. 
2005, CHRISTO et al. 2007, CECCHINI et al. 2009). 
There was a correlation in the group of patients with poor immunity 
(CD4+ count lower than 200 cells/mm3), but not in the group with a 
CD4+ count higher than 200 cells/mm3. However, the latter group showed 
a high correlation coefficient and level of significance close to 95% 
(r = 0.507 and p = 0.077) and consisted of only 12 patients for analysis. 
A study evaluating patients with mild cognitive symptoms and dementia 
reported a correlation between the two compartments only in subjects 
with a CD4+ count lower than 200 cells/mm3 (McARTHUR et al. 1997). 
However, another investigation evaluating patients with minor cognitive 
disorder and asymptomatic subjects found a correlation only in patients 
with a CD4+ count higher than 200 cells/mm3, but none of those patients 
presented opportunistic diseases or HIV-associated dementia as was the 
case in the present study. The presence of this correlation in less advanced 
stages was explained by the authors on the basis of the greater transit of 
lymphocytes to the CSF during earlier phases of infection (ELLIS et al. 
1997). The present study suggests that CD4+ count is not the only factor 
involved in the correlation between the two compartments.
There was a strong correlation between CSF and plasma viral load 
in the group with increased CSF protein content, whereas no correlation 
was observed in patients with normal CSF proteins. Patients with a 
protein content higher than 45 mg/dL most frequently had neurological 
diseases, especially opportunistic diseases, and most frequently presented 
increased cell counts. This finding suggests breakdown of the blood-
brain barrier which would explain the correlation between the two 
compartments, with CSF HIV-1 levels reflecting plasma levels, or even 
that the increase in viral replication in CSF occurs in parallel to the 
increase in plasma viral load and that HIV proteins and/or opportunistic 
diseases cause a host reaction generating globulins in CSF. However, the 
blood-brain barrier was not evaluated in the present study. In contrast, 
in patients with normal protein content viral load was not correlated, 
indicating the possible compartmentalization of HIV-1 RNA in CSF.
A correlation was observed in the group under HAART, with these 
patients showing a lower mean viral load both in plasma and CSF, 
suggesting that adequate control in one compartment leads to control of 
infection in the other. In the group not using HAART and without adequate 
control, no correlation was observed between the two compartments, a 
finding suggesting the existence of compartmentalization in this case. 
In the HAART era, ANTINORI et al. (2002) also found a correlation 
between plasma and CSF viral load only in patients using ARV drugs 
but not in treatment-naive individuals.
Studies disagree on the correlation between CSF and plasma viral 
load (BREW et al. 1997, ELLIS et al. 1997, CINQUE et al. 1998, 
MARTIN et al. 1998, FOUDRAINE et al. 1998, McARTHUR et al. 
1997, BOSSI et al. 1998, ROBERTSON et al. 1998). However, as seen 
in the present study, this may depend on the characteristics of the study 
population such as stage of HIV disease, presence of neurological disease, 
use and type of ARV therapy, CSF parameters and, possibly, other factors 
not investigated.
The present study found a correlation between CSF and plasma viral 
load in patients on HAART, in those with low immunity and in those 
with an increased CSF protein content, with CSF HIV-1 RNA levels 
probably reflecting plasma levels in these cases. These findings also 
suggest the active transporting of HIV through the blood-brain barrier 
or synchronized replication of the virus in plasma and brain, possibly 
mediated by cytokines (BOSSI et al. 1998). In contrast, no correlation 
between the two compartments was observed in patients who did not 
use HAART and those with normal CSF proteins and better immunity, 
indicating a possible compartmentalization of the virus in CSF and, 
consequently, plasma-independent intrathecal viral replication.
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RESUMO
Análise da correlação entre os níveis de RNA do HIV-1 no líquido 
cefalorraquidiano e plasma em pacientes com doença neurológica 
oportunista
Tem sido objeto de debate a questão se o RNA do HIV-1 no líquido 
cefalorraquidiano (LCR) é derivado da replicação viral no sistema 
nervoso central ou simplesmente reflete o tráfego de linfócitos infectados 
do compartimento sanguíneo. Alguns estudos não mostraram correlação 
entre a carga viral do plasma e LCR, mas outros sim. A falta de correlação 
entre os dois compartimentos sugere que a presença de RNA do HIV-1 não 
é simplesmente devido à passagem do vírus do plasma para o LCR, mas 
sim a uma replicação intratecal. Para avaliar a correlação entre os níveis 
de RNA do HIV-1 no plasma e no LCR e tentar identificar situações, na 
qual, não existe a correlação entre os dois compartimentos avaliaram-se 
setenta pacientes prospectivamente. A associação entre a carga viral do 
LCR e plasma foi avaliada na população total e em subgrupos de pacientes 
com características similares. A correlação entre os dois compartimentos 
foi observada em pacientes que estavam em uso da terapia antiretroviral 
(HAART), naqueles que tinham contagem de linfócitos CD4 menor que 
200 céls/mm3 e naqueles com aumento da concentração de proteínas 
no LCR. Por outro lado, não houve correlação para os pacientes que 
não tinham um controle virológico adequado, os que tinham contagem 
de CD4 maior que 200 céls/mm3 e aqueles que não estavam usando 
HAART. A correlação entre os dois compartimentos observada em 
alguns pacientes sugere que os níveis de RNA do HIV-1 no LCR podem 
refletir os níveis plasmáticos nestes pacientes. E a falta de correlação 
ente os dois compartimentos em pacientes que não usavam HAART, 
nos que tinham uma concentração de proteínas no LCR normal, e nos 
que não apresentavam bom controle virológico, indica provavelmente a 
compartimentalização do vírus no LCR e consequentemente replicação 
viral intratecal independente da do plasma.  
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